# OnCo record anakinra (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/anakinra/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "anakinra" ;
  schema:name "Anakinra"@en ;
  schema:description "Anakinra is an anti-inflammatory injection approved for arthritis and rare inflammatory diseases. After CAR-T cell therapy it is used to calm a severe inflammatory reaction (IEC-HS) and as a third-line option when cytokine release syndrome does not settle."@en ;
  schema:url <https://onco.cc/drugs/anakinra/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Anakinra> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9d74915-6606-4570-9c52-c4001d3177de>, <https://doi.org/10.1016/j.jtct.2023.03.006>, <https://doi.org/10.1136/jitc-2020-001511> ;
  onco:status "approved" ;
  onco:tag "supportive", "generic", "supportive-care-gaps-2026-11" ;
  onco:modality "Interleukin-1 receptor antagonist (recombinant protein, injection)" ;
  schema:alternateName "Kineret" ;
  onco:approval "US 2001: Rheumatoid arthritis; neonatal-onset multisystem inflammatory disease; deficiency of interleukin-1 receptor antagonist" ;
  onco:related <https://onco.cc/drugs/tocilizumab/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:terms <https://onco.cc/terms/crs/>, <https://onco.cc/terms/iec-hs/> .